ocular surface disease

Fighting against glaucoma-therapy related ocular surface diseaseOcular surface disease (OSD) and dry eye disease (DED) are very common problems in the elderly, and they both considerably decrease vision-related quality of life.
Cosmetic eyeliner tattoo as risk factor for ocular surface diseaseOphthalmology Times is pleased to announce Igor I. Bussel, MD, MS, MHA, and Deepinder K. Dhaliwal, MD (faculty sponsor), of the Department of Ophthalmology, University of Pittsburgh/UPMC Eye Center, Pittsburgh, as the second-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.
Biologic products increase dry eye optionsMany new diagnostic tools are available for dry eye and ocular surface disease (OSD). Treatments for dry eye and OSD have mixed results, however, said Bennie H. Jeng, MD.
Four ocular surface health questions to consider before cataract surgeryA thorough investigation of ocular surface health and initiation of any necessary treatment is the first step toward successful cataract surgery.
Testing at point of care for improved patient satisfaction, re-treatment ratesAfter spending a few months testing for dry eye and treating the tear film before doing preoperative measurements, the re-treatment rate dropped from 11% to 3%.
Targeting dry eye in glaucoma patients
Targeting dry eye in glaucoma patientsA poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
Advancements and cutting-edge science abound at the XXXV Congress of ESCRSIt will soon be time for the FIL – Feira Internacional de Lisboa in Lisbon, Portugal to open its doors to the ophthalmic community for the 35th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), taking place between the 7th and 11th October 2017.
Reviewing anterior segment ARVO 2017 postersSo much basic science research is presented at this meeting, and most of it will be years before it makes its way to clinical trials. Let’s concentrate on research that might be of use to us in the exam room very soon.